Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.

Autor: Minguela A; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Vasco-Mogorrón MA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Campillo JA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Cabañas V; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Remigia MJ; Department of Hematology, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia Valencia, Spain., Berenguer M; Hematology Service, General University Hospital Santa Lucía, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., García-Garay MC; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Blanquer M; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Cava C; Hematology Service, General University Hospital Rafael Méndez, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Galian JA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Gimeno L; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.; Human Anatomy Department, Medicine Faculty, Murcia University, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Soto-Ramírez MF; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Martínez-Hernández MD; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., de la Rubia J; Department of Hematology, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia Valencia, Spain., Teruel AI; Department of Hematology, University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia Valencia, Spain., Muro M; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB) Murcia, Spain., Periago A; Hematology Service, General University Hospital Rafael Méndez, Biomedical Research Institute of Murcia (IMIB) Murcia, Spain.

Publikováno v: American journal of cancer research [Am J Cancer Res] 2021 Sep 15; Vol. 11 (9), pp. 4438-4454. Date of Electronic Publication: 2021 Sep 15 (Print Publication: 2021).

Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms.

Autor: Vasco-Mogorrón MA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Campillo JA; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Periago A; Hematology Service, General University Hospital Rafael Méndez, Biomedical Research Institute of Murcia (IMIB), 30813 Murcia, Spain., Cabañas V; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Berenguer M; Hematology Service, General University Hospital Santa Lucía, Biomedical Research Institute of Murcia (IMIB), 30202 Murcia, Spain., García-Garay MC; Hematology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Gimeno L; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.; Human Anatomy Department, Medicine Faculty, Biomedical Research Institute of Murcia (IMIB), Murcia University, 30120 Murcia, Spain., Soto-Ramírez MF; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Martínez-Hernández MD; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Muro M; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain., Minguela A; Immunology Service, Clinic University Hospital Virgen de la Arrrixaca (HCUVA), Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Apr 09; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 09.